CD4 Count and Anti Retroviral Therapy for HIV Positive Patients With Cancer in Nigeria -A Pilot Study

BACKGROUND: Highly Active Anti Retroviral Treatment (HAART) improves the outcome of HIV positive patients treated for cancer. In our center HAART is only commenced in HIV positive patients with malignancy if the CD4 T lymphocyte count is less than 200 cells/ul. Presently, the outcome of treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntekim, Atara I., Folasire, Ayo. M.
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918360/
https://www.ncbi.nlm.nih.gov/pubmed/20703325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918360/
https://www.ncbi.nlm.nih.gov/pubmed/20703325

Ejemplares similares